The incumbent will serve as a Clinical Leader in Neurodegeneration, Neuroscience, with a focus on innovative late phase drug development for Alzheimer’s Disease projects.
$226,000 to $391,000 USD; Not specified; Medical, dental, vision, life insurance, disability, retirement plan, savings plan, long-term incentive program, paid time off
Must-have
Nice-to-have
Not specified